Yale Cardiovascular Medicine Grand Rounds: "Harnessing iPSC-derived Cardiac Progenitor Cells and Fibroblasts for Myocardial Repair"
- Understand the general outcomes from clinical cardiac cell therapy trials performed to date.
- Appreciate the different cell sources tested for cardiac repair.
- Describe relevant cardiovascular cell types differentiated from human iPS cells and their applications in cardiac repair.
UW – MadisonTimothy Kamp, MD, PhDProfessor
Coffee and Tea: Coffee & Tea.